Menu

Vaccine Results: A Post-Mortem Case Study


As those of you who have been reading my vaccine series know, I have had a great deal of difficulty in separating the fact from the fiction when it comes to the multiple Covid-19 vaccines. I have also made the best effort to see that the information I shared was both fact based and designed not to sway you one way or the other.

Since many have been vaccinated with one of the Covid-19 vaccines, there has been much talk and shared information about the “aftereffects” of the vaccine. I have been watching and reading as much as time allows regarding these concerns as well. I have reported on the VAERS statistics as posted on the CDC website, and I have found many of the same conditions that my patients have reported to me, ones that they or I feel should be reported as an adverse event. However, now we are beginning to see some research studies delving into more specific elements of the aftereffects of the vaccine. I would like to report on one such study today.

The study was published in the International Journal of Infectious Disease. The title is “First Case of Post-Mortem Study in a Patient Vaccinated Against SARS-CoV-2.” The study comes out of Germany.

The researchers reviewed the case of an 86-year-old patient who had received only the first does of the BNT162b2 mRNA COVID-19 vaccine (Pfizer vaccine) when he died of causes not directly related to a Covid-19 infection. They made the critical point that he did not have any of the symptoms associated with Covid-19, however he tested positive for SARS Covid-2 before he died. The researchers stated, “These results might suggest that the first vaccination induces immunogenicity but not sterile immunity.” In other words, they believe his immune system was prepared to prevent him from becoming ill from Covid, but it was not enough to stop the pathogen from replicating or spreading. (More explanation below).

The patient died four weeks after receiving the first vaccine dose. Now, I want to stop right there and say that the intent of this article is not to point a finger at the vaccine as the cause of death. I have my own thoughts about that, and I will let you make your own decisions about it after I enlighten you as to the multiple comorbidities that this gentleman already had.

The man’s past medical history included systemic arterial hypertension, chronic venous insufficiency, dementia, and prostate carcinoma. Ultimately, acute bronchopneumonia and renal tubular failure were noted as the cause of death upon autopsy. No typical signs of a Covid-19 infection were noted in these tissues. Every organ except the liver and the olfactory bulb demonstrated threshold SARS-CoV-2 values of antibodies.

LEVELS OF IMMUNITY

Immunogenicity means that the immune system is primed should it encounter the virus naturally. However, immunogenicity is difficult to measure, and the process to measure this level of immunity is extremely complex. The process poses many challenges, challenges that are magnified in the case of SARS-CoV-2. This is, in part, due to the fact that this virus is new.

The first challenge for researchers is to define a good response to the vaccine. They must determine what vaccine-induced response is sufficient for protection.

Sterile immunity means developing enough antibodies to actually fight off the virus. The researchers are stating that the one dose of the vaccine may have given a degree of immunogenicity but did not create enough sterile immunity to kill the virus after encountering it naturally.

PATIENT TIMELINE

After he received the vaccine, he had no symptoms. He continued to be totally asymptomatic for the following 2 weeks. Then 15 days after the vaccine he collapsed at breakfast. He was admitted to the hospital 3 days later. Since he was asymptomatic for SARS-CoV-2 and he tested negative for Covid-19, he was not isolated. Blood tests indicated iron deficiency anemia and kidney enzyme elevation. On day 19 post vaccine he was given IV iron, and on day 23 he was given IV glucose.

On day 24, he tested positive for Covid-19 with a high viral load. On day 25, his roommate tested positive for Covid-19 as well. It was assumed that the patient’s roommate infected him with the virus in spite of the fact that he had received the first dose of the vaccine. He now began to exhibit a fever and respiratory discomfort along with crackles in his lungs.

In spite of the administration of oxygen and antibiotic therapy, he expired the following day. The cause of death as noted earlier was pneumonia and kidney failure. When examined on autopsy, the pneumonia was bacterial in type and exhibited none of the typical Covid-19-associated lung inflammation or lung damage. The pneumonia, which partially caused his death was bacterial, and therefore not due to the virus. While his kidneys did demonstrate significant damage, this damage was not directly due to Covid-19. Most if not all of the kidney damage observed on autopsy by the researchers was chronic, and therefore predated the infection with Covid-19.

CONCLUSION

It appears in light of this research that, due to the fact that this individual received one dose of the vaccine and exhibited none of the typical signs or symptoms of a Covid-19 infection, he may have had a viral load which allowed him to transmit the virus yet not experience the typical symptoms of a Covid-19 infection.

This study may help us to further understand the efficacy of a single dose of the two-dose vaccine. It may also help us to recognize that a person so vaccinated might actually be a carrier of the virus without experiencing any of the typical symptoms associated with a Covid-19 infection.

The study also leaves some unanswered questions. Therefore we need to leave the doors open to further research and scrutiny.